<DOC>
	<DOCNO>NCT02660762</DOCNO>
	<brief_summary>This prospective study conduct evaluate efficacy safety profile Modified MRCUKALLⅫ/ECOGE2993 Regimen young adult newly diagnose , low-risk , Philadelphia chromosome negative acute lymphoblastic leukaemia .</brief_summary>
	<brief_title>Modified MRCUKALLⅫ/ECOGE2993 Regimen ALL</brief_title>
	<detailed_description>All patient receive modified BFM regimen derive MRCUKALLⅫ/ECOGE2993 Regimen.The difference follow : ( 1 ) cranial prophylactic radiotherapy omit ( 2 ) Pegaspargase use instead L- asparaginase patient . ( 3 ) Two additional Pegaspargase treatment add consolidation therapy .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>Etoposide phosphate</mesh_term>
	<mesh_term>Pegaspargase</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Cytarabine</mesh_term>
	<mesh_term>Daunorubicin</mesh_term>
	<mesh_term>6-Mercaptopurine</mesh_term>
	<mesh_term>Vincristine</mesh_term>
	<mesh_term>Thioguanine</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>newly diagnose ALL age:1835years WBC count 30×109/L ( B lineage ) ；WBC count 100×109/L ( T lineage ) absence ( 9 ; 22 ) , ( 1 ; 19 ) , ( 4 ; 11 ) 11q23 rearrangement receive chemotherapy radiotherapy Adequate renal function ( eg , serum creatinine≤1.5 mg/dL creatinine clearance ≥50 mL minute ) , hepatic function ( e.g , total bilirubin≤ 2 time upper limit normal aspartate alanine transaminase level ≤ 3 time upper limit normal ) mismatch inclusion criterion systematic central nervous system involvement , previous concomitant malignancy coexist medical problem could cause poor compliance study protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>